Fact CheckerSign in

NCT06029543Not yet recruiting

Permian Health Women's Lung Health Study

Source: ClinicalTrials.gov · Last updated 8 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this cross-sectional observational study is to estimate the prevalence of lung function impairment as measured by spirometry in a population of Gambian women aged 15 and older. The main question\[s\] it aims to answer are: * What is the prevalence of lung function impairment in Gambian women * What is the prevalence of eosinophilic inflammation in Gambian women Consenting participants will undergo * Spirometry * Fractional exhaled nitric oxide (FENO) testing * α1-antitrypsin testing in patients with lung function impairment as assessed by spirometry

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
350 (estimated)
First submitted
26 Aug 2023
Start date
Dec 2023
Primary completion date
Dec 2026
Lead sponsor
Permian Health Lung Institute
Diseases
COPD
NCT number
NCT06029543

What you commit to

  • Study type: Observational
  • Planned participants: 350
  • From Dec 2023 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any known history of active pulmonary disease (including TB) on treatment.

Age

  • Age \< 15 years

Other

  • Non-resident household member
  • Any acutely unwell individual
  • Pregnancy
  • Individuals unable or unwilling to give consent.

Who the study is looking for

  • Self-identified female sex
  • Age \> 15 years: This age cutoff was chosen (as opposed to 18) because of the unique cultural norms and practices in the country where experiences and exposures occur at an earlier age than women in Western countries.

Age in the registry: 15 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gamcotrap
Coordinator of this site? Confirm its status
KanifingThe GambiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.